Highlighting opportunities and resources particularly suited to UNH
On May 13-15, UNH’s federal relations firm -- Lewis Burke Associates (LBA) -- presented five one-hour webinars exclusively to the UNH research community on new and developing COVID-19-related funding opportunities from Federal agencies.
Webinars were presented discussing the Economic Development Administration (EDA); the U.S. Dept. of Agriculture (USDA); the National Science Foundation (NSF); Health-related agencies and telehealth; and the National Institutes of Health (NIH).
A significant portion of the $2T CARES Act (and subsequent stimulus packages) is allocated to research and development. Agencies have worked quickly to determine how to apply these funds within their missions, goals, and programs, resulting in a patchwork approach that differs across and within the agencies. For researchers, this presents a challenge to anticipate and respond quickly to funding opportunities as they arise. The LBA webinars offered a deeper dive into the select agencies to help researchers understand and navigate the changing environment. LBA’s goal was to demystify how agencies are responding to COVID-19 and give UNH researchers the tools to more confidently move forward.
** means posted or updated < 7 days since the date above
For organizations with more than one entry, new entries are added to the bottom of the list for that organization.
Agency for Healthcare Research and Quality (AHRQ)
Allen Institute for AI
American Lung Association
AXA Research Fund
Booz Allen Foundation
Council On Governmental Relations (COGR)
COVID-19 High Performance Computing (HPC) Consortium
Defense Logistics Agency (DLA)
Department of Defense (DoD)
**Department of Energy (DOE)
Department of Homeland Security (DHS)
Economic Development Administration (EDA)
Emergency Medicine Foundation
Emergent Ventures: Fast Grants
Environmental Protection Agency (EPA)
Institute of Museum and Library Services (IMLS)
International Fact Checking Network
Internet Society Foundation
Lean European Open Survey on SARS-CoV-2 Infected Patients
MIT Solve: Health Security and Pandemics Challenge
National Academies of Sciences, Engineering, and Medicine
National Aeronautics and Space Administration (NASA)
National Endowment for the Humanities (NEH)
**National Institutes of Health (NIH)
National Oceanic and Atmospheric Administration (NOAA)
National Science Foundation (NSF)
**Our World in Data
Patient-Centered Outcomes Research Institute (PCORI)
Research Data Alliance
Russell Sage Foundation
Social Science Research Council
UNH CoRE COVID-19 Pilot Research Partnerships
**U.S. Department of Agriculture (USDA)
World Health Organization (WHO)
23andMe COVID-19 Study
23andMe's objective is to investigate genetic links that could predispose individuals to severe COVID-19 symptoms. 23andMe’s large research database containing millions of genotyped individuals, combined with their ability to quickly survey our research participants, means that they are well placed to address questions related to the genetics of COVID-19 outcomes. If they are able to identify genetic links with COVID-19 outcomes, it may ultimately help researchers and scientists better understand the biology of the disease and why some experience more severe symptoms than others.
23andMe is eager to learn of ideas about how their database can support other PI's research on COVID-19 or SARS-CoV-2. Researchers with ideas for collaboration projects can contact 23andMe at the email provided on the website.
Deadline: Open until further notice Details
Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01)
AHRQ has published a Funding Opportunity Announcement (FOA) that invites R01 grant applications for funding to support novel, high-impact studies evaluating the responsiveness of healthcare delivery systems, healthcare professionals, and the overall U.S. healthcare system to the COVID-19 pandemic.
AHRQ is interested in funding critical research focused on evaluating topics such as effects on quality, safety, and value of health system response to COVID-19; the role of primary care practices and professionals during the COVID-19 epidemic; understanding how the response to COVID-19 affected socially vulnerable populations and people with multiple chronic conditions; and digital healthcare including innovations and challenges encountered in the rapid expansion of telehealth response to COVID-19.
AHRQ encourages multi-method, rapid-cycle research with the ability to: produce and disseminate initial findings (e.g., observations, lessons learned, or findings) within 6 months after award and then regularly throughout the remainder of the award period.
Deadline: June 15, 2020 RFA-HS-20-003
COVID-19 Open Research Dataset (CORD-19)
The Semantic Scholar team at the Allen Institute for AI has partnered with leading research groups to provide CORD-19, a free resource of more than 128,000 scholarly articles about the novel coronavirus for use by the global research community. Details
COVID-19 and Emerging Respiratory Viruses Research Award
The American Lung Associatin is looking for proposals to advance research directly be related to COVID-19 and other novel respiratory viruses with pandemic potential. This award of $100,000 per year for up to two years is intended to support investigators with evidence of ongoing excellence and productivity in a related field.
The Lung Association is interested in applications that address the following types of clinical, basic, translational, and population health questions:
- A new understanding of the basic biology of respiratory viruses that could lead to better treatment and prevention
- Development of novel therapeutics and vaccines
- Understanding host factors that alter response to these infections
- Understanding individual, regional, or social factors increasing or decreasing community spread of COVID-19 and other respiratory viruses
- Case tracking and epidemiological approaches to understanding COVID-19 and other respiratory viruses
Deadine: May 30, 2020 Details
Mitigating Risk in the Wake of the Covid-19 Pandemic
The AXA Research Fund has committed support to emergency research initiatives at the beginning of the crisis; however, it is also necessary to inform its aftermath as well as a potential second wave, particularly in lower income countries. It is also a time to start questioning how to better prepare for the next crisis – be it epidemic, climate or ecological – while we learn from the current one.
This Research Fund has launced a flash call for projects in the following areas:
- Protecting vulnerable populations from epidemics and catastrophes, including COVID-19: be it migrants, informal settlements, workers in the informal economy, isolated people, people with disabilities, the elderly
- Improving data collection and quality in health: how can data and technology help us get out of the crisis, understand it and mitigate it? How can it inform future containment and epidemic control?
- Understanding the effects of confinement and social distancing: what are the effects of confinement and social distancing on society and households? What are the mental health consequences? The social and domestic repercussions?
- Early warning and preparedness: how do we re-enforce our health infrastructure and ecosystem (including medical devices and drug supply) to be better prepared and how do we protect our health workers and caregivers?
- Preserving the environment and our health: connections between climate change, biodiversity loss and the origin of viral disease including socioeconomic dynamics leading to infectious disease outbreaks and sanitary crisis; Learnings from COVID-19 for mitigating future related crises in climate and biodiversity
Preference will be given to projects with a local focus and potential applicability on a global scale.
PI Eligibility: Mid-career researchers between PhD + 6 years and PhD + 10 years maximum
Required Effort: Research project must involve full-time work for the duration of the grant (with an exceptional acceptance of up to 20% time dedicated to teaching)
Institutional Limits: Only one candidate per department
If you plan to submit, please send an email to Kathy Cataneo to secure your spot.
Deadline: May 7, 2020 10:00 AM EDT (4:00 PM Paris time) Details
The Booz Allen Foundation has established a $1 million Innovation Fund to help nonprofits, entrepreneurs, thought leaders, innovators at colleges and universities, and startups and small businesses harness the power of data, technology, and diverse intellectual capital to improve COVID-19 relief efforts and make a difference. It wants to surface the most innovative solutions and empower the individuals and organizations behind those solutions to drive their development and implementation.
Through the Innovation Fund, the Foundation is specifically targeting solutions and projects that will build lasting community resilience through protecting vulnerable populations and frontline workers or providing for the safe return to work. Nonprofits can apply for grants of up to $100,000. Individuals, teams of individuals, and eligible for-profit organizations can apply for microgrants of up to $10,000. Certain eligibility requirements apply.
Deadline: June 5, 2020 Details
Digital Transformation Institute (C3.ai DTI)
The C3.ai Digital Transformation Institute (C3.ai DTI) is a new new public-private research consortium that aims to use artificial intelligence (AI) and advanced computing to research solutions for COVID-19. Managed by the University of Illinois at Urbana-Champaign (UIUC) and the University of California, Berkeley, the consortium also involves C3.ai, Microsoft Corporation, Princeton University, the University of Chicago, the Massachusetts Institute of Technology, Carnegie Mellon University, and the National Center for Supercomputing Applications at UIUC.
The Institute has announced an initial call for proposals, AI Techniques to Mitigate Pandemic, which brings together Health and AI research. Up to $5.8 million in awards will be funded from this first call, ranging from $100,000 to $500,000 each.
Deadline: May 1, 2020 Details
C3.ai COVID-19 Data Lake
The C3.ai COVID-19 Data Lake uniquely integrates multiple data sources in a unified data model, ready for analysis – not just a list of links or a collection of data sets. Access data at no charge with any utility that supports RESTful APIs. Details
Institutional and Agency Responses to COVID-19 and Additional Resources
COGR (an association of research universities and affiliated medical centers and independent research institutes) is maintaining a list of resources from the federal agencies, including agency guidance specific to federal award impact on individual grants and grantees, and from other organizations with ties to higher education. The list is updated frequently. Details
Researchers are invited to submit COVID-19 related research proposals to the consortium which will then be reviewed for matching with computing resources from one of the partner institutions. XSEDE Website
The National Center for Atmospheric Research (NCAR) has joined the COVID-19 High Performance Computing Consortium, making the NCAR-operated Cheyenne supercomputer available to scientists across the country who are working to glean insights into the novel coronavirus that has spread worldwide. Details
Funded by DOE and NSF, COVID Scholar is a COVID-19 literature search powered by advanced NLP algorithms. It uses echnology based on the Vespa.ai open source project. Details
DLA is now accepting Other Transaction Authority whitepapers on the following problem statements that support COVID-19:
- Personal Protection Equipment (PPE) Re-Use and Decontamination
- Prototype PPE: N95 Equivalent Masks
DLA will be reviewing white papers and taking action as they are received due to the critical need for this equipment.
Deadline: May 4, 2020 1:00 PM EDT Details
Air Force Acquisition COVID-19 Task Force (DAF ACT) Commercial Solution Opening (CSO)
The DAF ACT is seeking innovative solutions for commercial technologies that can support the DAF ACT's mission to “provide relief, resilience, recovery, and stability to the nation in response to the COVID-19 pandemic.” The CSO, a vehicle for future solicitations, is open to defense contractors, large and small businesses, and research institutions, with a focus on non-traditional organizations that do not typically work with the government.
DAF ACT Areas of Interest include the following COVID-19 related mission focus areas:
- Combating the Spread (predictive analytics, next hotspot, threat to current activities, decision support, etc.)
- Welfare of citizens (effects to transportation, movement of people and goods, education and development, physical training, regular HR functions, job transition, etc.)
- Readiness (continuing operations through the outbreak, coordinating with allies and partners, continuing long term projects, etc.)
- Logistics (security and protection, supply chain protection and assessment, etc.)
- Industrial base impacts (small businesses, payments, contracts, large system programs, protection and expansion of critical assets, etc.)
- Medical (telehealth, medical capacity and sustainment, medical supplies and equipment, etc.)
- Other solutions that support the national response to COVID-19
The Air Force expects to announce the initial Area of Interest for solution brief submissions:
Congressionally Directed Medical Research Programs (CDMRP)
RFP: Peer Reviewed Medical Research Program Investigator-Initiated Research Award for Emerging Viral Diseases and Respiratory Health
The PRMRP challenges the scientific and clinical communities to address at least one of the FY20 PRMRP Topic Areas of Emerging Viral Diseases and Respiratory Health (described in the FOA) with original ideas that foster new directions along the entire spectrum of research and clinical care. The proposed research must be relevant to active duty Service members, Veterans, military beneficiaries, and/or the American public.
Deadlines: Preapplications, May 28, 2020; Full proposals, June 12, 2020 Details
Medical Technology Enterprise Consortium (METC)
A pre-announcement has been release for a Request for Project Proposals (RPP) to rapidly develop and deploy the National Emergency Telecritical Care Network (NETCCN) – a cloud-based, low-resource, stand-alone health information management system for the creation and coordination of flexible and extendable “virtual critical care wards.” Technology Focus Areas for potential other funding opportunities in 2020 are also listed. Details
RPP: Development of Treatments for COVID-19
A Request for Project Proposals (RPP) focused on developing prototypes for therapeutics that can treat COVID-19 has been issued. Specifically, MTEC is seeking “treatments with potential application to the prevention of COVID-19 infection” and “therapeutics that can be administered in a non-hospital environment.”
Deadline: White papers, April 8, 2020 at 12:00 pm ET
FOA: MTEC-20-09-COVID-19_Treatment_MIDRP “Development of Treatments for COVID-19”
RPP: Wearable Diagnostic for Detection of COVID-19 Infection
This RPP seeks wearable devices that can conduct continuous physiological monitoring without impacting the wearer’s daily activities and that are focused on pre- and very early symptomatic detection of COVID-19 infection. Proposed projects must currently be in development or commercially available given the “urgent need for development of rapid, accurate wearable diagnostics to identify and isolate pre-symptomatic COVID-19 cases and track/prevent the spread of the virus/
Deadline: May 13,2020 at 12:00 pm ET
FOA: MTEC-20-12-COVID-19_Diagnostics "Wearable Diagnostic for Detection of COVID-19 Infection"
Additional RPPs are anticipated related to topics described in MTEC’s pre-announcement, including:
- Prophylactic(s)/Therapeutic(s) that can prevent and/or treat in a rapid manner (few hours to 2 days) potentially in a non-hospital environment. Repurposing FDA-approved drugs/biologics for prevention/treatment of COVID-19 or testing of drugs/biologics that have already demonstrated safety in humans for the prevention/treatment of COVID-19 are preferred
- Disease predictive modeling that provides early warning through data capture from several different streams of data to include social media and artificial intelligence (AI) parameter decision tools that would provide actionable information to medical service providers and command structures
- Patient monitoring, tracking, and management system for in-home or non-hospital environment patient tele-health services to include interface into the Cerner electronic health record
Newton Award for Transformative Ideas during the COVID-19 Pandemic
Up to 10 awards of $10,000-$100,000 will be presented to a single investigator or team of up to two investigators that develops a “transformative idea” to resolve challenges, advance frontiers, and set new paradigms in areas of immense potential benefit to DoD and the nation at large. Proposals should aim to produce novel conceptual frameworks or theory-based approaches that present disruptive ways of thinking about fundamental scientific problems that have evaded resolution, propose new, paradigm-shifting scientific directions, and/or address fundamental and important questions that are argued to be undervalued by the scientific community. Approaches can include analytical reasoning, calculations, simulations, and thought experiments. While data collection and production are therefore allowed, all supporting data should be generated without the use of laboratory-based experimentation or instrumentation.
Given the novelty of and circumstances surrounding this one-time Funding Opportunity Announcement (FOA), the objective of this program is to generate proposals that are equally novel and pioneering. Therefore, this FOA should be viewed as an opportunity to propose work outside the bounds of traditional proposals.
Deadline: May 15, 2020 Details
Unite and Fight
The Air Force also announced that its effort, known as “Unite and Fight,” has expanded to include all of DOD under forthcoming efforts and solicitations, so that all of the Service Branches, DOD components, and the Office of the Secretary of Defense (OSD) can evaluate and potentially fund proposals. Details
Potential areas of DOD interest
- Point-of-care diagnostic that provides rapid and accurate determination on exposure to COVID-19
- Prophylactic(s)/Therapeutic(s) that can prevent and/or treat in a rapid manner (few hours to 2 days) potentially in a non-hospital environment.
(Repurposing FDA-approved drugs/biologics for prevention/treatment of COVID- 19 or testing of drugs/biologics that have already demonstrated safety in humans are preferred.)
- Disease predictive modeling that provides early warning through data capture from several different streams of data to include social media and artificial intelligence (AI) parameter decision tools that would provide actionable information to medical service providers and command structures
- Patient monitoring, tracking, and management system for in-home or non-hospital environment patient tele- health services to include interface into the Cerner electronic health record
Department of Energy/COVID-19 Rapid Research Response
DOE is requesting input on strategic, priority research directions that may be undertaken using DOE user facilities, computational resources, and enabling infrastructure.
National Virtual Biotechnology Laboratory (NVBL)
DOE has launched a National Virtual Biotechnology Laboratory (NVBL) to open up DOE national laboratory user facilities and specialized instrumentation to all sectors of the research community to address COVID-19. The NVBL is taking advantage of DOE user facilities, including light and neutron sources, nanoscale science centers, sequencing and bio-characterization facilities, and high performance computer facilities, to address key challenges in responding to the COVID-19 threat.
Activities that could be supported include developing innovations in testing capabilities, identifying new targets for medical therapeutics, providing epidemiological and logistical support, and addressing supply chain bottlenecks. Details
Oak Ridge National Lab, Neutron Sciences - Rapid Access for COVID-19 Research
The DOE Basic Energy Sciences advanced neutron sources will provide remote rapid access to advanced user facilities to support research into the COVID-19 virus and the search for effective diagnostics and therapies. Facilities that will be made available at the Spallation Neutron Source (SNS) and High Flux Isotope Reactor (HFIR) at Oak Ridge National Laboratory (ORNL), include neutron macromolecular crystallography, small-angle scattering, reflectometry, spectroscopy and imaging beamlines.
SNS and HFIR beamlines are supported by staff with expertise in neutron structural biology, biophysics, chemistry, and nanoscale materials science and engineering and could be used to help to develop physical, chemical and environmental controls to virus transmission, infection and replication, and guide in the development of new diagnostics and therapeutics of disease.
Researchers who would like to use these resources should submit a short rapid access proposal, outlining experiment aims and scope.
Deadline: Ongoing Details
A facility scientist will contact applicants regarding their proposals within 2 days
Master Question List for COVID-19 (caused by SARS-CoV-2)
The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) is maintaing a “master question list” that quickly summarizes what is known, what additional information is needed, and who may be working to address such fundamental questions as, “What is the infectious dose?” and “How long does the virus persist in the environment?”
The Master Question List (MQL) is intended to quickly to present the current state of available information to government decision makers in the operational response to COVID-19 and allow structured and scientifically guided discussions across the federal government without burdening them with the need to review scientific reports, and to prevent duplication of efforts by highlighting and coordinating research. Details
Multidisciplinary Research into Epidemics and Pandemics in Response to the Outbreak of SARS-CoV-2
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has issued a call for a multidisciplinary funding initiative to support projects addressing the prevention, early detection, containment and investigation of the causes, impacts and management of epidemics and pandemics, taking the example of SARS-CoV-2 and other microorganisms and viruses that are pathogenic to humans.
This includes, for example, the investigation of:
- the challenges and effects of an epidemic or pandemic and of measures taken for healthcare systems;
- psychological, social and cultural factors in the emergence, spread and treatment of epidemics and pandemics and the legal and ethical implications;
- the impacts on global and regional economic development, production and value creation chains, logistics, transport and communication;
- fundamental biological and medical aspects of a pathogen and the associated symptoms, as well as therapeutic methods or preventive measures in combination with one or more of the above topic areas
Proposals will also be considered for:
- projects designed to gather and record basic data on the current epidemic and current countermeasures, which can serve as the basis for future retrospective analyses
- projects involving the simulation of the spread and consequences of pandemics and the effectiveness of interventions
Deadlines: Letter of Intent, July 1, 2020 Proposal, September 1, 2020 Details
FY 2020 Public Works and Economic Adjustment Assistance Notice of Funding Opportunity (NOFO) - CARES Act Addendum
The Department of Commerce’s (DOC) Economic Development Administration (EDA) will support a broad array of development initiatives with potential to expand economic activity and recovery through funding for construction, non-construction (i.e. strategic development, infrastructure development strategies etc.), technical assistance, and planning. The agency will also provide support for additional regional assistance beyond EAA activities for qualified applicants, including innovation grants that are similar to EDA’s Build to Scale program (formerly “Regional Innovation Strategies”).
According to the NOFO, examples of projects funded by the program include “economic recovery planning and preparing or updating resiliency plans to respond to future pandemics, implementing entrepreneurial support programs to diversify economies, and constructing public works and facilities that will support economic recovery, including the deployment of broadband for purposes including supporting telehealth and remote learning for job skills.”
As with all EDA awards, coordination with EDA’s regional offices is crucial for ensuring proposed projects fit the scope, eligibility intentions and funding amounts designated for the program.
COVID-19 Research Grant Opportunities
The Emergency Medicine Foundation is awarding funding of up to $100,000 in new research grants on emergency medicine areas related to COVID-19. Topics may include, but are not limited to, the following:
- Personal Protective Equipment (PPE), including Design, Cleaning, Re-use
- Ventilator Scarcity
- Laboratory Testing
- Rapid Screening, Triage and Testing
- Clinical Diagnosis
- Epidemiology of Disease
- Diagnostic Radiology, including Point of Care Ultrasound
- Emergency Medicine Workforce, including Safety
- Emergency Physician Wellness
- Special Populations, such as High Risk, Homeless, Non-English Speaking, Transplantation Patients
Deadline: June 5, 2020 Details
Fast Grants Available
"If you are a scientist at an academic institution currently working on a COVID-19 related project that could help with the COVID-19 pandemic within the next six months and in need of funding, we invite you to apply for a Fast Grant. Fast Grants are $10k to $500k and decisions are made in under 48 hours. If we approve the grant, you'll receive payment as quickly as your university can receive it."
Fast Grants Paused
Due to receipt of a very large number of qualified submissions, Fast Grant applications are currently paused. If Fast Grants secures additional funding, issuing of new grants will be resumed. Potential applicants can visit the website to sign up to be notifed if applications are reopened and to view a list of some of the awards made. (Recipients can decline to be identifed publicly.)
WEBINAR: EPA Expands Research on COVID-19 in the Environment
EPA scientists are building on a foundation of world-class research by applying their knowledge to reduce the risk of exposure to SARS-CoV-2, the virus that causes COVID-19. This research will help states & territories, tribes, and local governments, including public health agencies guide homeowners, business owners, and others reduce the risk of exposure.
This Joint Homeland Security Research/Tools & Resources Webinar will highlight research EPA is working on with the Centers for Disease Control and Prevention (CDC) including:
- Environmental Cleanup and Disinfection
- Wastewater Virus Detection:
- Salivary Antibody Assay Development
The webinar will take place on Wednesday, May 27, 2020, 2:00 - 3:00 P.M. ET.
COVID-19 Analysis on Usegalaxy
This resource provides publicly accessible infrastructure and workflows for SARS-CoV-2 data analyses. It presents best practices for the analysis of SARS-CoV-2 data (genomics, evolution, and cheminformatics) using open source tools and public cyberinfrastructure for transparent, reproducible analyses of viral datasets. Details
COVID-19 Research Grants
Google Cloud research credits will be provided for leveraging Google’s computing capabilities and infrastructure to study therapies, vaccines, track critical data, and identify new ways to combat COVID-19.
Deadline: Ongoing Details
COVID-19 Public Dataset Program
To aid researchers, data scientists, and analysts in the effort to combat COVID-19, Google Cloud has made a hosted repository of public datasets, (e.g., Johns Hopkins Center for Systems Science and Engineering (JHU CSSE); the Global Health Data from the World Bank, OpenStreetMap data) free to access and query. Researchers can also use BigQuery ML to train advanced machine learning models with this data right inside BigQuery at no additional cost. Training is available to help teach the fundamentals of working with these datasets on Google Cloud. Details
Call for Code Global Challenge - Take on COVID-19
With the unprecedented effect of COVID-19, unite to help communities across the globe deal with the impact of the greatest crisis of modern times. Use open source technology in the cloud to build solutions that can provide crisis communication, remote education, and community cooperation.
Some developers know what they want to build for Call for Code, but for those who don't, there are starter kits. These quick-start guides help you understand the scope of the problem and start building applications tied to easy-to-understand use cases in a matter of minutes.
Deadline: Open Details
IMLS CARES Act Grants for Museums and Libraries
The IMLS CARES Act Grants for Museums and Libraries grant program invites project proposals that focus on preserving jobs, training staff, addressing the digital divide, planning for reopening, and providing technical support and capacity building for digital inclusion and engagement while prioritizing services for high-need communities. IMLS encourages efforts to develop programs, tools, models, partnerships, and other resources that will address immediate concerns and have the potential to inspire and benefit museums and libraries throughout the nation. Projects will take place between September 1, 2020 and August 31, 2022.
A recording and a transcript of the May 14th Informational Webinar is available here.
CoronaVirusFacts Alliance - Call for research proposals
Since Jan. 24, coordinated by the International Fact-Checking Network, more than 100 fact-checkers from 74 countries have been working together in the largest collaborative fact-checking effort ever launched: the CoronaVirusFacts / DatosCoronaVirus Alliance. On March 19, the alliance published its database of fact-checked content, which identified more than 800 falsehoods about the spreading pandemic. Today, the CoronaVirusFacts database offers more than 5,000 fact checks that have been published by 88 organizations in 44 different languages. It is the most comprehensive and active database about COVID-19 mis/disinformation.
The next step for the CoronaVirusFacts Alliance is to more fully tap the expertise and work of academics and researchers. Fact-checkers understand that the alliance's database gathers many in-depth stories and can offer a better understanding of the "infodemic." By working together, fact-checkers and academic researchers will expand the knowledge base about COVID-19 and further elevate the fight against health mis/disinformation. Access to the full dataset will be provided only to vetted researchers to prevent monetization and exploitation of the dataset created by the fact-checkers.
The International Fact-Checking Network is accepting proposals from academics and researchers.
Possible topics to be addressed include but are not limited to:
- Investigating claims and the spread of mis/disinformation on COVID-19 across different media platforms and different national or language environments.
- Exploring themes, styles, imagery or other features of mis/disinformation around COVID-19.
- Investigating the characteristics and behaviors of actors (both individuals and groups) that surfaced and helped spread COVID-19 hoaxes.
- Finding ways to measure the impact of the fact-checking activity when addressing certain hoaxes.
- Analyzing the limitations and challenges that fact-checkers have faced to tackle mis/disinformation during the COVID-19 outbreak. Surfacing questions and areas of improvement for fact-checkers in future collaborative efforts.
The International Fact-Checking Network will provide all accepted applicants with access to the data accumulated by the CoronavirusFacts Alliance.
A limited number of the accepted proposals – those that can clearly demonstrate the need for funding – could be awarded up to $10,000 to conduct the study.
To request this support, researchers should demonstrate that their work will have an imminent impact on the fact-checking community and that the IFCN's funding is crucial for their work.
Deadline: May 29, 2020 Details
Accepted proposals will be notified by June 12. Grant recipients will be notified by June 19.
Emergency Response Grant Programme with Focus on COVID-19
The Internet Society Foundation has launched a new emergency response grant programme, targeting organizations working on projects that utilize the Internet to improve lives during or in response to an emergency situation. With a 2020 focus on the COVID-19 coronavirus response, the Foundation will solicit grant applications from programmes that respond to the pandemic both during the immediate period of the crisis and in the aftermath. The Foundation is committed to working with organizations that take known Internet-based technical solutions and apply them to COVID-19 responses, or are pivoting from their regular activities to create new projects or reworked technical solutions that respond to the pandemic.
A few examples of projects that the Foundation may consider for funding include:
- applications that accelerate and coordinate humanitarian response
- services that promote and enable distance learning for students
- platforms that establish new pathways to alternative livelihoods
- indexes that demonstrate urban and/or rural pandemic preparedness
Grants of $250,000 – $500,000 will be awarded to organizations for projects lasting up to 12 months.
Deadline: May 17, 2020 Details
LEOSS Public Data Set
The LEOSS public data set constitutes patient data from the LEOSS cohort after a data cleaning process, e.g., verifications for a complete documentation of course of disease and plausibility checks. The public data set is anonymized using the LEOSS data protection concept.
Variables included are:
- month of diagnosis
- classification of the present clinical phases
- presence of administered vasopressor agents
- performed invasive ventilation
- superinfections (proven/suspected/probable as one category)
- remaining symptoms in the recovery phase
Grants of 100,000 to 500,000 euro (approximately $110,000 to $550,000) for up to three years are available for the focus area of pandemic preparedness and fighting new emerging viral infectious diseases. The 2020 research grants program is open to scientists in all career stages who are affiliated with any research-based institution, university or company in all countries all over the world.
Deadline: August 31, 2020 Details
Microsoft AI for Health COVID-19
This grant program provides Azure cloud and High-Performance Computing capabilities to assist work bynonprofits, academia, and governments that contributes to our understanding of COVID-19 and/or improves our ability to respond to the pandemic. Microsoft's team of AI for Health data science experts, whose mission is to improve the health of people and communities worldwide, is also open to collaborations with COVID-19 researchers as they tackle this critical challenge. More broadly, Microsoft’s research scientists across the world, spanning computer science, biology, medicine, and public health, will also be available to provide advice and collaborate per mutual interest.
Deadline: June 15th, 2020 or until further notice Details
Health Security and Pandemics Challenge
MIT Solve, a marketplace for social impact innovation is seeking technological solutions that can slow and track the spread of an emerging outbreak, for example by improving individual hygiene, developing low-cost rapid diagnostics, analyzing data that informs decision making, and providing tools that support and protect health workers. Looking toward the long-term, Solve is also seeking solutions that focus on preventative and mitigation measures that strengthen access to affordable primary healthcare systems, enhance disease surveillance systems, and improve healthcare supply chains. The initial grant amount is $10,000, with the possibility for larger awards in later phases.
Deadline: June 18, 2020 Details
Mozilla Open Source Support Program (MOSS) COVID-19 Solutions Fund
The COVID-19 Solutions Fund, as part of the Mozilla Open Source Support Program (MOSS), will provide awards of up to $50,000 each to open source technology projects which are responding to the COVID-19 pandemic in some way.
The Fund will accept applications for reasonably mature projects that can immediately deploy the funding to develop:
- hardware (e.g., an open source ventilator)
- software (e.g., a platform that connects hospitals with people who have 3D printers who can print parts for that open source ventilator)
- software that solves for secondary effects of COVID-19 (e.g., a browser plugin that combats COVID related misinformation)
Deadline: Ongoing Details
NASEM Forum on Postsecondary Response to COVID-19: Hubs of Knowledge and Resources for the Nation
The Board on Higher Education of the National Academies of Sciences, Engineering, and Medicine hosted a series of conversations to bring together academic, industry, government, and civic leaders across the country to understand the varied facets of what has happened so far, what is currently happening, and what is expected to happen in the weeks and months ahead. Each conversation focused on a specific topic related to how the 4,000+ colleges and universities—and the researchers who work there—are supporting the response efforts.
April 24: What are possible long term implications of postsecondary responses?
April 23: What are the implications of this being a truly global event?
April 22: What are models for volunteering?
April 17: How can we provide policy advice to the nation faster?
April 16: How can we crowd-source scientists to improve public information?
April 15: How can and are laboratories shifting research agendas?
April 09: How can researchers help the national response efforts?
Video recordings are available of the sessions. Details
Societal Experts Action Network (SEAN)
The National Academies of Sciences, Engineering, and Medicine, in collaboration with the National Science Foundation, will establish the Societal Experts Action Network (SEAN), a network of leading individuals and institutions in the social and behavioral sciences to facilitate rapid responses to actionable social, behavioral, and economic-related COVID-19 questions from decision-makers. Details
Rapid Response and Novel Research in Earth Science Solicitation: NNH20ZDA001N-RRNES
Research Opportunities in Space and Earth Sciences (ROSES) 2020 Program Element A.28 Rapid Response and Novel Research in Earth Science (RRNES) is an opportunity for “making innovative use of NASA satellite data to address regional-to-global environmental, economic, and/or societal impacts of the COVID-19 pandemic.”
Prior to proposal submission, PIs must contact:
(1) the most relevant NASA program officer (http://science.nasa.gov/researchers/sara/program-officers-list/#earth) AND
(2) the current Rapid Response and Novel Research in Earth Science (RRNES) program officer (listed in the solicitation)
DEADLINE: Ongoing until March 29, 2021 Details
NASA ESD anticipates reviewing proposals within 10 days of submission.
NASA's Space Apps COVID-19 Challenge!
From May 30-31, 2020, citizen scientists around the world will solve challenges related to COVID-19 using NASA’s open-source data in an all-virtual, global hackathon.
The focus will be on the following four themes:
- Learning about the virus and its spread using Space-based data
- Local response/change and solution
- Impacts of COVID-19 on the Earth system/Earth system response
- Economic opportunity, impact, and recovery during and following COVID-19
Complete challenge statements will be posted on the Space Apps website the week before the hackathon.
All NASA, ESA, and JAXA civil servants, contractors, and current and past awardees and their teams are eligible to serve as subject-matter experts. Personnel from other US government agencies are also eligible. You will be matched with appropriate challenges, if possible.
Depending on your availability, you are invited to participate in the following ways:
Engage with participants in the chat rooms over hackathon weekend (May 30-31)
Judge project submissions (June to mid-July, exact dates TBD)
The National Endowment for the Humanities (NEH) will receive $75 million in supplemental funding to assist cultural institutions affected by the coronavirus as part of the $2.2 trillion CARES Act economic stabilization plan.
Approximately 40 percent of the appropriation, or $30 million, will be distributed directly to the 56 state and jurisdictional humanities councils, based on the standard population formula used for their annual appropriation. The remaining 60 percent, or $45 million, will support at-risk humanities positions and projects at museums, libraries and archives, historic sites, colleges and universities, and other cultural nonprofits that have been financially impacted by the coronavirus.
NEH CARES: Cultural Institutions
Emergency relief grants will provide up to $300,000 to cultural nonprofits to support a range of humanities activities across the fields of education, preservation and access, public programming, digital humanities, and scholarly research through December 31, 2020. Funding is to be used for short-term activities that emphasize retaining or hiring humanities staff at cultural organizations across the country to maintain or adapt critical programs during the pandemic.
NEH invites applications from eligible organizations seeking support for at-risk humanities positions and projects that have been impacted by the coronavirus. Through this funding opportunity, NEH will award grants to museums, libraries and archives, historic sites, independent research institutions, professional organizations, colleges and universities, and other cultural organizations across the country to help these entities continue to advance their mission during the interruption of their operations due to the coronavirus pandemic.
Applicants will be informed of funding decisions by June 2020.
Current grantees may be eligible to apply for an administrative supplement. Contact your program officer to discuss proposed research on SARS-CoV-2/COVID-2019.
See Funding Opportunities Specific to COVID-19 for IC-specific notices of interest.
Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has issued an NOSI to highlight the urgent need for accelerating the development, translation, and commercialization of technologies to address Coronavirus Disease 2019 (COVID-19). The NIBIB is seeking applications to develop life-saving technologies that can be ready for commercialization within one to two years.
Example technologies include, but are not limited to:
- Rapid point-of-care and home-based testing/diagnostics
- Wearable, implantable, and remote sensors/imagers for physiological monitoring
- Medical imaging technologies and algorithms/artificial intelligence (AI) for rapid detection, diagnosis, and monitoring of lung infection
- Non-contact sensing and imaging for rapid mass screening and vital sign assessment
- Digital health platforms and models that integrate data, assess risk, and provide illness surveillance and management tools
- Technologies (including simulation platforms) for training healthcare workers and optimizing clinical workflows
- Robotic and automation technologies to limit caregivers’ exposure and/or reduce burden on the healthcare system
- Technologies for protecting healthcare workers, first responders, and caregivers
- Oxygenation systems (e.g., ECMO, ventilators, intubation) and components designed for rapid deployment, access, and potential operation by minimally trained personnel
- High-confidence disinfection technologies
- Novel therapeutic strategies using engineered biological systems, including cell-based and synthetic biology technologies
Applicants must follow the NOSI-specific instructions regarding submission and application content.
Deadline: Varies Details
Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
The National Institute of Environmental Health Sciences (NIEHS) has issued an NOSI to address the urgent need for mission-relevant research to understand the impact of environmental exposures on Coronavirus Disease 2019 (COVID-19) and its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). NIEHS is particularly interested in applications that will provide insight into the role of environmental exposures in pathogenicity, transmission, individual susceptibility, or prevention and intervention strategies.
Possible research interests include, but are not limited to the following:
- Examine the role of environmental exposures in impacting individual susceptibility to SARS-Cov-2 infection, or the development and severity of COVID-19 disease
- Investigate the role of lifestyle factors (e.g. diet, physical activity) as modifiers of the effects of environmental exposures on the development or severity of COVID-19 disease
- Leverage existing biological samples or data from human or animal research studies to test hypotheses examining the impact of environmental exposures on susceptibility to SARS-Cov-2 infection and COVID-19 disease severity or progression (e.g. detection of SARS-Cov-2 infection in an existing environmental epidemiology study)
- Utilize previously developed research tools or technology platforms that can be applied to understand how environmental exposures impact COVID-19 spread, or disease progression and severity (e.g. personal exposure monitoring, geospatial mapping, risk modeling tools, biomarkers to detect infection)
- Apply multi-omics approaches that can accelerate identification of biomarkers/metabolic signatures of infection or disease progression using animal models as well as in study participants of existing environmental health studies
- Understand the role of exposure-induced perturbations in respiratory microbiome and its contributions to COVID-19 susceptibility and disease progression
- Assess the impact of COVID-19-related interventions (including social or physical distancing or public health messaging) on changes in the spread of COVID-19 as well as environmental exposures and related human health outcomes
- Determine the potential health effects of increased personal/community use of disinfection products for COVID-19 control
- Develop or apply educational, community-based, or other public health strategies that address the intersection between environmental exposures and COVID-19
- Identify climate or weather-related factors that influence population susceptibility to SARS-Cov-2 infection and COVID-19 disease
- Examine the potential impact of environmental health disparities on the spread of COVID-19 disease
NIEHS considers the COVID-19 pandemic to be an unpredictable event that provides a limited window of opportunity to collect human biological samples or environmental exposure data (e.g., measuring levels of pollutants in air or water during a long period of social distancing due to COVID-19). Accordingly, applications for new R21 grants (projects that do not build off of an existing NIEHS grant) should be submitted to RFA-ES-19-011 “Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)” provided the time-sensitive criteria described therein are met.
Applicants must follow the NOSI-specific instructions regarding submission and application content.
Notice of Special Interest (NOSI): Data Driven Research on Coronavirus Disease 2019 (COVID-19)
The National Library of Medicine (NLM) has issued a Notice of Special Interest (NOSI) to highlight the urgent need for innovative high-risk/high impact research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) in relation to NLM’s strategic goal of fostering data driven research.
NLM is encouraging the submission of R21 applications to address the following research areas of interest:
- Methods for mining clinical data that can be used to identify or predict presence of COVID-19 in biomedical phenotype data, or other relevant topics such as discovery of risks for infection by SARS-Cov-2 viruses, use of standard terminologies for these viruses in federated health data sets
- Public health surveillance methods that mines genomic, viromic, health data, environmental data and/or data from other pertinent sources such as social media, to identify spread and impact of SARS-Cov-2
Applications are expected to focus on informatics and data science methods to help address the COVID-19 pandemic in a timely manner. Applications that are not responsive will be withdrawn without review
Deadline: June 16, 2020 Details
Rapid Acceleration of Diagnostics (RADx)
RADx is a fast-track technology development program supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN). RADx will support novel solutions that build the U.S. capacity for SARS-CoV-2 testing up to 100-fold above what is achievable with standard approaches. RADx is structured to deliver innovative testing strategies to the public as soon as late summer 2020 and is an accelerated and comprehensive multi-pronged effort by NIH to make SARS-CoV-2 testing readily available to every American.
NIBIB is providing substantial support to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19. NIBIB will support the full range of product development including commercialization and product distribution.
Deadline: Rolling submissions until further notice Details
Project proposals will be reviewed within a week of receipt.
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
The National Institute of Allergy and Infectious Diseases (NIAID) has released 2 funding announcements to provide expedited funding for new research on SARS-CoV-2 and COVID-19. The opportunities solict applications for new projects via the R21 (Exploratory/Developmental Research Grant) and R01 (Research Project Grant) funding mechanisms.
Areas of high priority are listed with detail in the FOAs and include, but are not limited to, the following:
- Studies to understand critical aspects of viral infection, replication and pathogenesis
- Studies to understand critical aspects of viral transmission
- Identification and characterization of the onset and duration of immunity in healthy and at-risk populations
- Virologic and serologic surveillance studies and natural history studies to understand the origin of the virus including the animal host reservoir, potential intermediate hosts, factors leading to spill over events, evidence of continued spill over events and studies at the human-animal interface
- Studies to assess and characterize the natural history and long-term consequences of SARS-CoV-2 infection in various human populations including at risk populations
- Development or improvement of clinical diagnostic tests for SARS-CoV-2 to increase the sensitivity, specificity and ability to provide rapid results
- Development and testing of SARS-CoV-2 therapeutic candidates, in relevant in vitro, ex vivo or animal models
- Development of SARS-CoV-2-specific or broadly protective coronavirus vaccine candidates
- Studies to inform the development of vaccination strategies for at-risk populations including use of age-specific adjuvants or novel antigen formulations/dosing
- Development of assays and animal models
- Assess animal models for SARS-CoV-2 and how the models compare to human infection including animal models that represent at risk populations (elderly, immunocompromised, very young, pregnant models)
- Development of animal models for transmission experiments
- Development of organoid culture models and/or ex vivo explant models
- Computational modeling studies to identify and evaluate interventions to protect at-risk populations and for making public health policy decisions for control and mitigation measures
- Study interactions and impact between SARS-CoV-2 and other respiratory pathogens including influenza (e.g., co-infections, interference)
- Comparative studies of SARS-CoV-2 to other coronaviruses including SARS-CoV-1 and MERS
- Data science approaches to develop algorithms, models, and informatics solutions
Notice of Additional Due Date and Additional “Areas of Focus Especially of Interest” of PAR-19-373 and PAR-19-384, Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01)
PAR-19-373 and PAR-19-384 solicit research projects that seek to model the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in health, illness, recovery, and overall wellbeing. An additional application due date of June 8, 2020, has been added for these funding opportunity announcements (FOAs) and Areas of Focus #1 and #3 have been modified to include an emphasis on needs arising from the COVID-19 pandemic.
Open-Access Data and Computational Resources to Address COVID-19
This list by the Office of Data Science Strategy is a compilation of COVID-19 open-access data and computational resources provided by federal agencies, including NIH, public consortia, and private entities. These resources are freely available to researchers. Details
**NIAID Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
NIAID has issued a Notice of Special Interest (NOSI) to highlight the need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) in select scientific areas using PA-20-200, the NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed).
In order to rapidly improve our understanding and available control measures for SARS-CoV-2 and COVID-19, NIAID is encouraging the submission of applications to address the following research areas of interest:
- Studies to understand critical aspects of viral infection, replication, pathogenesis, and transmission;
- Studies on the evolution and emergence of SARS-CoV-2 viruses including the identification of factors that affect viral host-range and virulence;
- Development of sensitive, specific, and rapid clinical diagnostic tests for SARS-CoV-2;
- Development of SARS-COV-2 therapeutic candidates, especially broad-spectrum therapeutics against multiple coronavirus strains;
- Identification and evaluation of the innate, cellular and humoral immune responses to SARS-CoV-2 infection, including, but not limited to: cross-reactive antibodies from individuals exposed to SARS-CoV-2 and other coronaviruses; viral epitopes critical for T cell activation or antibody binding and neutralization; immune-mediated pathology or host factors that might predispose to severe infection; and studies to examine duration of protection or the potential for reinfection; and
- Development of SARS-CoV-2 vaccine candidates, including approaches for pan-coronavirus protection, that include emerging antigen design strategies, novel platforms or delivery approaches, adjuvants, or assessing cross-neutralization potential of SARS-CoV vaccine candidates.
Deadlines: June 16, 2020, October 16, 2020, February 16, 2021, June 14, 2021 PA-20-200
In addition, two FOAs have been issued that provide an expedited funding mechanism for research on SARS-CoV-2 and COVID-19 using the R01 and R21 funding mechanisms. Applicants interested in pursuing NIH funding support utilizing either of these mechanisms is encouraged to consider the following funding opportunities:
- Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) Deadline: Rolling until April 30, 2021 PAR-20-178
- Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) Deadline: Rolling until April 30, 2021 PAR-20-177
**NIH Director’s Emergency Early Independence Awards (DP5 Clinical Trial Optional)
Due to the COVID-19 public health emergency, the Common Fund will dedicate funds provided by the CARES Act to support a total of 5-10 Early Independence Awards (through this FOA) or Transformative Research Awards (through RFA-RM-20-020) that bring new, innovative perspectives and approaches to the prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally. Any relevant area of coronavirus SARS-CoV-2 research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics, and other related topics. As with all High-Risk, High-Reward Research program applications, innovation may be technological or conceptual.
The NIH Director's Early Independence Award (a component of the High-Risk, High-Reward Research program of the NIH Common Fund) supports exceptional junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement.
This FOA solicits applications responsive only to the COVID-19 public health emergency through support of the CARES Act. All other Early Independence Award applications must be submitted in response to RFA-RM-20-014.
Deadline: September 4, 2020 RFA-RM-20-021
**NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional)
Due to the COVID-19 public health emergency, the Common Fund will dedicate funds provided by the CARES Act to support a total of 5-10 Transformative Research Awards (through this FOA) or Early Independence Awards (through RFA-RM-20-021) that bring new, innovative perspectives and approaches to the prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally. Any relevant area of coronavirus SARS-CoV-2 research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics, and other related topics. As with all High-Risk, High-Reward Research program applications, innovation may be technological or conceptual.
The NIH Director’s Transformative Research Award Program supports individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the nation’s research workforce. Individuals from diverse backgrounds and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement. The NIH Director’s Transformative Research Award is a component of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund.
No preliminary data are required. Projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce a major impact on SARS-CoV-2 prevention, preparation, or response.
This FOA solicits applications responsive only to the COVID-19 public health emergency through support of the CARES Act. All other Transformative Research Award applications must be submitted in response to RFA-RM-20-013.
Deadline: September 30, 2020 RFA-RM-20-020
Emergency Notices of Funding Opportunities may be published for less than 30 days, allowing for quick turnaround and reviews.
BACK TO TOP
Non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge
Proposals may be submitted through existing funding opportunities and via the Rapid Response Research (RAPID) funding mechanism.
Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) (Revised April 3, 2020)
Office of Advanced Cyberinfrastructure (OAC)
RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and/or software infrastructure development activities.
SBIR/STTR Phase I Proposals Addressing COVID-19
U.S.-based businesses are invited to submit Phase I SBIR/STTR proposals focused on “the development and deployment of new technologies, products, processes, and services” that have the potential to help respond to COVID-19.
The following areas of research are highlighted: artificial intelligence, digital health, diagnostics, distributed ledger, environmental technologies, medical devices, pharmaceutical technologies, disinfection and sterilization, and filtration and separations.
Research Experiences for Undergraduates Supplemental Funding in Computer and Information Science and Engineering
The Directorate for Computer and Information Science and Engineering (CISE) issued a Dear Colleague Letter (DCL) restating the opportunity to apply for funding supplements to active CISE awards for Research Experiences for Undergraduates (REU). These supplements are intended to address the disruption to undergraduates caused by the pandemic and states, “In light of COVID-19, and to enable the CISE research community to provide additional opportunities to engage undergraduates who are US citizens and permanent residents in research pathways, CISE reiterates this interest via this DCL.”
COVID Information Commons
Funded by an NSF RAPID award, researchers at Columbia University will create a COVID Information Commons (CIC) website to facilitate knowledge sharing and collaboration across various COVID research efforts, especially focusing on all the NSF-funded COVID Rapid Response Research (RAPID) projects. The CIC will serve as a resource for researchers as well as decision-makers from government, academia, not-for-profit and industry to leverage each other's findings, and invest in and accelerate the most promising research to mitigate the broad societal impacts of the COVID-19 pandemic. It will also serve as a model for integrated knowledge sharing and collaboration on other public health challenges, in benefit to society.
Projects will be able to enter and publish information about their efforts in ways that are most relevant and user-friendly for a variety of potential stakeholders from academia, industry, government, and non-profit sectors. Information will be organized in multiple ways, for example, by research topics areas and by geography. In addition to information from NSF COVID-19 RAPID projects, the COVID Information Commons will incorporate coronavirus-related information from NSF Open Knowledge Network projects, as well as from other NSF research projects in general. Details
**Statistics and Research: Coronavirus Pandemic (COVID-19)
COVID-19 pandemic data are collated, visualized and interpreted by country, deaths, cases, tests, mortality risk, and policy responses. Country profiles include interactive visualizations, explanations of the presented metrics, and the details on the sources of the data.A Data Explorer brings together the global data on testing for COVID-19, and the counts of confirmed cases and deaths, with each metric presented in a straightforward line chart or in a trajectory charts, which align all countries at the start of the outbreak).Detailed pages present the latest data together with detailed explanations of what we can learn from this data: where does the data come from? What are the limitations that we need to be aware of? And what does the data tell us about the coronavirus pandemic?
The dataset is updated daily and can be downloaded. Details
COVID-19 Targeted PFA
This program with an accelerated timeline will support innovative, high-impact studies that fit clearly within PCORI's core mission of patient-engaged and patient-centered comparative clinical effectiveness research. Its objectives are to (1) strengthen the understanding of different approaches to mitigate the impact of COVID-19 on individuals, communities, healthcare providers, and healthcare systems; and (2) provide evidence to inform clinical and public health responses, decision making, and planning.
PCORI encourages the use of diverse methods, including interventional studies and the use of natural experiments, to conduct research on an accelerated timeline. Applicants are encouraged to complete primary outcomes collection and provide actionable findings in no longer than 12 months. Hybrid designs, which can provide insight into implementation approaches in the context of evidence generation, will also be welcome.
This funding announcement has three targeted priority areas. The research questions articulated in each of the priority areas below are not the only questions of interest; other relevant questions within these priority areas will also be considered. The priority areas are:
- Adaptations to healthcare delivery: What has been the impact on patient-centered outcomes of alternative healthcare delivery models (e.g., telehealth, hospital at home) that are being implemented in response to COVID-19? What has been learned about barriers and facilitators to their effective implementation?
- Impact of COVID-19 on vulnerable populations: What are effective clinical pathways to improve outcomes for the most vulnerable and higher risk patients? What are effective system- or organizational-level responses to prevent or mitigate the impact of COVID-19 in low-income and low-resource settings that serve vulnerable populations? Vulnerable populations include but are not limited to Native Americans or Alaskan Natives, African Americans, and other racial, ethnic, or sexual and gender minorities; rural communities; incarcerated populations; people who are homeless or unstably housed; individuals with intellectual, developmental, or physical disabilities; individuals with chronic conditions; and individuals facing increased exposure because they are unable to work remotely.
- Impact of COVID-19 on healthcare workforce well-being, management, and training: What policies, practices, or programs are effective in helping health systems quickly shift human resources, redeploy healthcare workers, and train current and new healthcare workers to fill certain healthcare delivery needs? What are effective strategies to protect the physical and/or mental well-being of the healthcare workforce?
Deadline: May 26, 2020 Details
This PFA may be re-issued if funds are available.
RDA COVID-19 Working Group
The overarching objectives of this Working Group (WG) are:
to clearly define detailed guidelines on data sharing under the present COVID-19 circumstances to help stakeholders follow best practices to maximize the efficiency of their work
to develop guidelines for policymakers to maximise timely data sharing and appropriate responses in such health emergencies
- to address the interests of researchers, policy makers, funders, publishers, and providers of data sharing infrastructures
The group will address the development of such detailed guidelines on the deposit of different data sources in any common data hub or platform. The guidelines aim at developing a system for data sharing in public health emergencies that supports scientific research and policy making, including an overarching framework, common tools and processes, and principles that can be embedded in research practice. The guidelines to be developed will address general aspects related to the principles the data should adhere to (FAIR and other principles), as well as specificities related to five thematic and two overarching areas. Details
New COVID-19 Focused Funding Guidelines for May 21 Deadline for Research Grants
For this deadline, RSF will only consider Letters of Intent (LOIs) that satisfy at least one of the following criteria:
- the research is so timely and time-sensitive that the project must start before April 1, 2021
- the research analyzes social, political, economic, or psychological disruptions resulting from the coronavirus crisis that affect social and living conditions in the United States
All LOIs must focus on issues related to the foundation’s core program areas and special initiatives:
- Behavioral Economics
- Decision-Making and Human Behavior in Context
- Future of Work
- Race, Ethnicity, and Immigration
- Social, Political, and Economic Inequality
SafeGraph COVID-19 Data Consortium
SafeGraph is providing free access to its various datasets to help researchers, non-profits, and governments around the world with response to COVID-19 (Coronavirus). So far, 1,000+ organizations such as the CDC are already in the consortium and are using SafeGraph and partner company datasets at no-cost. The data includes aggregated and anonymized datasets on social distancing and foot traffic to businesses. Details
Resources and Connections
This website was created by some “Big Science” (particle physics and related fields) researchers, research software engineers and computational science researchers to:
(1) Make connections to enable (non-medical) researchers to contribute to understanding and combating this global problem and/or its economic and societal impacts. How can researchers with significant data analytics, machine learning, simulation, software, computing, hardware development and organizational skills contribute? Are there places where marshaling large “Big Science”-style distributed teams to tackle problems can be useful?
(2) Explore how all types of research activities can adapt and be effective in an era in which face-to-face meetings and travel are greatly reduced and conferences are being canceled. What are the lessons being learned and new ideas for how to approach this?
The website provides links to various information sources on COVID-19 related research, resources and research projects. The group is curating information about, and promoting, various COVID-19 related projects done by this larger scientific community. They are also actively engaged through discussion in the Slack channel and periodic meetings in building further connections and enabling related discussions. Details
Rapid-Response Grants on Covid-19 and the Social Sciences
In partnership with the Henry Luce Foundation, The Social Science Research Council (SSRC), as part of its Covid-19 Initiative, seeks proposals from across the social sciences and related fields that address the social, economic, cultural, psychological, and political impact of Covid-19 in the United States and globally, as well as responses to the pandemic’s wide-ranging effects.
The SSRC’s Covid-19 Rapid-Response Grants thus support innovative research projects that deploy remote research methods to shed light on both the short- and potential long-term effects of Covid-19 across a range of issues. These include:
- “Social distancing” and virtual social interaction
- Governance and democracy
- Public trust and (dis)information
- Social inequality and the pandemic’s disproportionate effects by race and ethnicity
- The lessons of past disasters, and responses to them, for the present
- The role of religious ideas, practices, and institutions in responding to the pandemic
- The workplace and labor markets
- Technology, surveillance, and ethics
- The uses of, and the limits to, modeling in responses to the pandemic’s effects and in scenario planning
These topics are illustrative. Applicants are welcome to propose others. Projects focused on groups most affected by the pandemic are especially encouraged, as are those that can constructively inform responses across communities, public actors and institutions, and others.
Deadline: June 1, 2020 Deadline
Research Grants on Education: COVID-19 Related Special Grant Cycle
These grant will support rigorous, intellectually ambitious, and technically sound education research projects that will contribute to understanding the rapid shifts in education in this time of crisis and change. We are especially interested in supporting two primary categories of projects:
- Studies that aim to understand and disrupt the reproduction and deepening of educational inequality caused by the COVID-19 crisis
- Research projects that are working to reimagine educational opportunities in these times, particularly to remake and imagine anew forms of equitable education
Awards will be made for up to $50,000 for projects ranging from one to three years.
Coronavirus Response Fund
The Stevens Initiative is providing resources to help education, exchange, and non-profit organizations in the United States and the Middle East and North Africa conduct virtual exchange programs to engage young people and educators affected by the pandemic.The Initiative encourages proposals by consortia that include organizations with relevant and complementary experience, capacities, and networks. The maximum grant period of performance window is June 1 to August 31, 2020; awards will range from $20,000 to $100,000.
Activities must be conducted in the United States and in one or more of the following countries: Algeria, Bahrain, Egypt, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, the Palestinian Territories, Qatar, Saudi Arabia, Syria, Tunisia, United Arab Emirates, and Yemen. Programs involving refugees from these countries who are currently in countries not listed above are also eligible.
Proposed projects are encouraged to focus on the following topics:
- Technology and computing
- World affairs and global studies
- Business and entrepreneurship
- Language learning and practice
- Public health and/or the coronavirus pandemic
Deadline: Rolling basis until June 12, 2020 Details
As part of UNH’s ongoing response to COVID-19 and in the spirit of our land grant mission, CoRE is funding PRP projects directly related to the COVID-19 pandemic to improve public health and welfare at UNH, across New Hampshire, throughout the region, nationally, or globally.
UNH’s Collaborative Research Excellence (CoRE) initiative will make seed funding available by Monday, May 4, 2020 for Pilot Research Partnership (PRP) projects directly related to the COVID-19 pandemic. Up to $30,000/project will be available for one-year collaborative research projects with strong potential to garner future funding from external sources (including industrial support) and/or with outstanding commercial potential. Projects may be intra-institutional, multi-institutional, or public-private partnerships.
Applicants are encouraged to think broadly and creatively about how their expertise can address relevant areas of research, including, but not limited to:
- Impact and recovery in vulnerable communities
- Diagnostics, models, therapeutics, vaccine development
- Telemedicine and telehealth
- Distance learning
- Workforce preparedness
- Mental health and substance use disorders resulting from the pandemic
- Environmental transmission via contaminated surfaces or materials
- Economic impacts and recovery
- Public perception and behavior
- Disaster preparedness
- Resource (e.g., PPE) allocation and redistribution
- Environmental and ecological impacts
Deadline: 9:00 A.M. on Monday, April 27, 2020 Details
On April 16, the National Institute of Food and Agriculture (NIFA) hosted a webinar for its Land Grant University and other science partners to clarify clarify answers to frequently asked questions about how the current situation caused by COVID-19 will affect NIFA programs.
A recording of the webinar, the slide deck, and the frequently asked questions(FAQ) document on, which the presentation was based, is available at https://nifa.usda.gov/coronavirus.
The FAQ document will be updated regularly -- Latest update: 5/13/20
COVID-19 Rapid Response to Novel Coronavirus (SARS-CoV-2) Impacts Across Food and Agricultural Systems
NIFA has added a COVID-19 Rapid Response to Novel Coronavirus (SARS-CoV-2) Impacts Across Food and Agricultural Systems program area to the Agricultural and Food Research Initiative (AFRI) RFA. It is described on pp. 72-75 of the updated RFA.
Two-year interdisciplinary research, extension, and/or integrated projects of up to $1 million should address one or more of four areas of priority:
- Health and Security of Livestock
- Well-being of Farm, Food Service Providers, and Rural Americans
- Economic Security
- Food Safety
- focus on critical and urgent research, extension, or integrated solutions in response to the COVID-19 pandemic and its impacts on the nation’s food and agricultural system
- include strategies and knowledge that can be rapidly implemented to minimize or eliminate COVID-19 impacts on the nation’s food and agricultural system
- explicitly highlight how the activities would directly address urgent stakeholder needs relating to COVID-19
Collaborations with minority-serving institutions are encouraged.
Deadline: June 4, 2020 Details & updated RFA
NIFA will expedite application evaluation and awards review to ensure rapid project start-up.
Note that all the remaining AFRI deadlines are as published in the 2020 RFA and review will proceed according to the usual timetable.
**Rural Health and Safety Education Competitive Grants Program (RHSE)
The RHSE program proposals are expected to be community-based outreach education programs, such as those conducted through Human Science extension outreach that provide individuals and families with: information as to the value of good health at any age; information to increase individual or family’s motivation to take more responsibility for their own health; information regarding rural environmental health issues that directly impact human health; information about and access to health promotion and educational activities; and training for volunteers and health services providers concerning health promotion and health care services for individuals and families in cooperation with state, local, and community partners.
NIFA requests applications for the FY 2020 Rural Health and Safety Education (RHSE) Competitive Grant Program. $1M (of he total $4M) is set aside to support the utilization of telehealth, telemedicine, and distance learning strategies for education and training in minority rural communities related to opioids or preventing spread of SARS-CoV-2 and in mitigating infection and transmission of SARS-CoV2.
Deadline: July 1, 2020 Details
R&D Blueprint and COVID-19
As part of WHO’s response to the COVID-19 pandemic, the R&D Blueprint was activated to accelerate diagnostics, vaccines and therapeutics for this novel coronavirus. The Blueprint aims to improve coordination between scientists and global health professionals, accelerate the research and development process, and develop new norms and standards to learn from and improve upon the global response.
Building on the response to recent outbreaks of Ebola virus disease, SARS-CoV and MERS-CoV, the R&D Blueprint has facilitated a coordinated and accelerated response to COVID-19, including an unprecedented program to develop a vaccine, research into potential pharmaceutical treatments and strengthened channels for information sharing between countries. Details
Global Research on Novel Coronavirus 2019
WHO is gathering the latest international multilingual scientific findings and knowledge on COVID-19. The global literature cited in the WHO COVID-19 database is updated daily (Monday through Friday) from searches of bibliographic databases, hand searching, and the addition of other expert-referred scientific articles. This database represents a comprehensive multilingual source of current literature on the topic. While it may not be exhaustive, new research is added regularly. Details
XPRIZE Pandemic Alliance
To accelerate the world’s response to the greatest challenge we face today, XPRIZE is launching the XPRIZE Pandemic Alliance, powered by the XPRIZE Data Collaborative, a powerful platform for collaboration, combining data, AI tools, and bleeding edge insights and ideas with a community of innovators on the fringe.
Comprised of a collection of exclusive datasets and AI capabilities spanning multiple domains, the XPRIZE Data Collaborative democratizes access to data and the tools needed to develop solutions, thus enabling teams and collaborators to use these valuable assets to solve the world’s most immediate challenges. Our goal is to incentivize and capture the collective intelligence and wisdom of the global community to identify and develop solutions based on data, beginning with the global pandemic we face today and extending further within the domains of health, economy, environment, and equity for all .
Currently in the phase of Recruiting Partners/Organizing Existing Efforts, the XPRIZE Pandemic Alliance invites the world’s innovators to share solutions, learnings, and resources and allow the global community to 1) participate in the latest breakthroughs, research and solutions in development; and 2) ask the network for help in scaling the impact of promising and vetted COVID-19 solutions.
As part of this Alliance, XPRIZE will host and launch a series of rapid data challenges, which may include creating an early warning system for future pandemics, predictive modeling for public health resource allocation, and developing more efficient and affordable diagnostics, treatments, and cures that can be produced rapidly. Details
Funding Opportunity Database
Ongoing Projects/ Literature
Scientific Community Expertise
Phone: (603) 862-5338
Phone: (603) 862-0357
Phone: (603) 862-4377
Phone: (603) 862-2002
Phone: (603) 862-5255